Valion Bio, Inc. Common Stock VBIO
$3.07
-14.01%
at last close
Market Cap$3.17 million
P/E Ratio—
Div Yield—
Volume292.9K
52-Week Range
$2.79$32.50
Key Stats
- Today's Range
- $2.88 – $3.46
- 50-Day Range
- $2.79 – $32.50
- 52-Week Range
- $2.79 – $32.50
- Volume
- 293K shs
- Average Volume
- 769K shs
- Market Cap
- $3.17 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 34.09%
- Days to Cover
- 1.00
About Valion Bio, Inc. Common Stock
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Related Stocks
Compare head-to-head: VBIO vs LLY·VBIO vs JNJ·VBIO vs ABBV·VBIO vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.